Biogen (BIIB) Net Margin (2009 - 2026)
Biogen (BIIB) recorded quarterly Net Margin of 12.89% in Q1 2026, up 701.06% quarter-over-quarter from 2.15% in Q4 2025, and up 300.0% on a YoY basis from 3.22% in Q1 2025.
Biogen (BIIB) Net Margin (2009 - 2026) Analysis & Trends
Biogen's Net Margin history runs 18 years deep, the most recent figure standing at 12.89% for Q1 2026.
- In Q1 2026, Net Margin rose 300.0% year-over-year to 12.89%; the TTM figure through Mar 2026 stood at 13.81% (down 126.0% YoY), while the FY2025 annual figure was 13.07%, down 380.0% from the prior year.
- Net Margin was 12.89% for Q1 2026 at Biogen, up from 2.15% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 45.59% in Q3 2022 to a low of 2.54% in Q3 2023.
- Historically, Net Margin has averaged 17.48% across 5 years, with a median of 16.13% in 2023.
- The sharpest annual moves came in 2022 and 2023: Net Margin surged 5044 bps in 2022, then slumped 4813 bps in 2023.
- A 5-year view of Net Margin shows it stood at 21.97% in 2022, then plunged by 53 bps to 10.43% in 2023, then advanced by 4 bps to 10.86% in 2024, then sank by 120 bps to 2.15% in 2025, then surged by 701 bps to 12.89% in 2026.
- The last three Net Margin figures came in at 12.89% (Q1 2026), 2.15% (Q4 2025), and 18.4% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 22.77% |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 37.36% |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 21.76% |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 4.65% |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | -0.56% |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 23.32% |
| 10 | Biogen | 28.97 Bn | 24.68 Bn | 1.82 Bn | 12.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.89% |
| Dec 31, 2025 | -2.15% |
| Sep 30, 2025 | 18.40% |
| Jun 30, 2025 | 24.00% |
| Mar 31, 2025 | 9.89% |
| Dec 31, 2024 | 10.86% |
| Sep 30, 2024 | 15.76% |
| Jun 30, 2024 | 23.68% |
| Mar 31, 2024 | 17.18% |
| Dec 31, 2023 | 10.43% |
| Sep 30, 2023 | -2.54% |
| Jun 30, 2023 | 24.42% |
| Mar 31, 2023 | 16.13% |
| Dec 31, 2022 | 21.97% |
| Sep 30, 2022 | 45.59% |
| Jun 30, 2022 | 41.01% |
| Mar 31, 2022 | 9.61% |
| Dec 31, 2021 | -3.72% |
| Sep 30, 2021 | -4.85% |
| Jun 30, 2021 | 19.04% |